Product Recalls in Wyoming

Product recalls affecting Wyoming — including food, drugs, consumer products, medical devices, and vehicles distributed to Wyoming. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,573 recalls have been distributed to Wyoming in the last 12 months.

48,219 total recalls
2,573 in last 12 months

Showing 781800 of 13,375 recalls

DrugDecember 6, 2024· Aurobindo Pharma USA Inc

Recalled Item: Nebivolol Tablets Recalled by Aurobindo Pharma USA Inc Due to CGMP...

The Issue: CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 4, 2024· AvKARE

Recalled Item: Nitrofurantoin Capsules Recalled by AvKARE Due to Failed Dissolution...

The Issue: Failed Dissolution Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 2, 2024· RemedyRepack Inc.

Recalled Item: Duloxetine Delayed-Release Capsules Recalled by RemedyRepack Inc. Due to...

The Issue: CGMP Deviations; presence of N-nitroso-duloxetine impurity above recommended...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 27, 2024· AvKARE

Recalled Item: Cinacalcet Tablets Recalled by AvKARE Due to CGMP deviations: Presence of...

The Issue: CGMP deviations: Presence of Nitrosamine Drug Substance Related Impurity...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 27, 2024· AvKARE

Recalled Item: Cinacalcet Tablets Recalled by AvKARE Due to CGMP deviations: Presence of...

The Issue: CGMP deviations: Presence of Nitrosamine Drug Substance Related Impurity...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 27, 2024· AvKARE

Recalled Item: Cinacalcet Tablets Recalled by AvKARE Due to CGMP deviations: Presence of...

The Issue: CGMP deviations: Presence of Nitrosamine Drug Substance Related Impurity...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 26, 2024· Curium US, LLC

Recalled Item: Kit for the Preparation of Technetium Tc 99m Sestamibi Injection Recalled by...

The Issue: Lack of Assurance of Sterility; Improper crimps on vials impacting the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 25, 2024· Macleods Pharmaceuticals Ltd

Recalled Item: Olanzapine Tablets Recalled by Macleods Pharmaceuticals Ltd Due to Failed...

The Issue: Failed Impurities/Degradation Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 22, 2024· Jubilant Draximage Inc., dba Jubilant Radiopharma

Recalled Item: Kit for the Preparation of Technetium Tc 99m Sulfur Colloid Injection...

The Issue: Failed Stability Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 22, 2024· Provepharm Inc.

Recalled Item: Dihydroergotamine Mesylate Injection Recalled by Provepharm Inc. Due to...

The Issue: Discoloration

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 22, 2024· Apothecus Pharmaceutical Corp.

Recalled Item: VCF Recalled by Apothecus Pharmaceutical Corp. Due to CGMP deviations: out...

The Issue: CGMP deviations: out of specifications for assay

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 22, 2024· Dr. Reddy's Laboratories, Inc.

Recalled Item: Javygtor (sapropterin dihydrochloride) Tablets 100mg Recalled by Dr. Reddy's...

The Issue: Failed Impurities/Degradation Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugNovember 19, 2024· Mylan Institutional, Inc.

Recalled Item: Levothyroxine Sodium Tablets Recalled by Mylan Institutional, Inc. Due to...

The Issue: Subpotent and Superpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 19, 2024· Mylan Institutional, Inc.

Recalled Item: Levothyroxine Sodium Tablets Recalled by Mylan Institutional, Inc. Due to...

The Issue: Subpotent and Superpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 19, 2024· Mylan Institutional, Inc.

Recalled Item: Levothyroxine Sodium Tablets Recalled by Mylan Institutional, Inc. Due to...

The Issue: Subpotent and Superpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 19, 2024· Mylan Institutional, Inc.

Recalled Item: Levothyroxine Sodium Tablets Recalled by Mylan Institutional, Inc. Due to...

The Issue: Subpotent and Superpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 19, 2024· Mylan Institutional, Inc.

Recalled Item: Levothyroxine Sodium Tablets Recalled by Mylan Institutional, Inc. Due to...

The Issue: Subpotent and Superpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 19, 2024· Mylan Institutional, Inc.

Recalled Item: Levothyroxine Sodium Tablets Recalled by Mylan Institutional, Inc. Due to...

The Issue: Subpotent and Superpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 19, 2024· Rising Pharma Holding, Inc.

Recalled Item: Duloxetine DR Capsules USP 60 mg Recalled by Rising Pharma Holding, Inc. Due...

The Issue: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 19, 2024· Rising Pharma Holding, Inc.

Recalled Item: Duloxetine Delayed-Release Capsules USP Recalled by Rising Pharma Holding,...

The Issue: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund